These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 33149567)
21. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Fuso L; Mores N; Valente S; Malerba M; Montuschi P Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722 [TBL] [Abstract][Full Text] [Related]
23. A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. Huang WC; Chen CY; Liao WC; Wu BR; Chen WC; Tu CY; Chen CH; Cheng WC Int J Chron Obstruct Pulmon Dis; 2021; 16():1555-1568. PubMed ID: 34113089 [TBL] [Abstract][Full Text] [Related]
24. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894 [TBL] [Abstract][Full Text] [Related]
25. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
26. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA; Donohue JF Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301 [TBL] [Abstract][Full Text] [Related]
27. Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. Dalon F; Roche N; Belhassen M; Nolin M; Pegliasco H; Deslée G; Housset B; Devillier P; Van Ganse E Int J Chron Obstruct Pulmon Dis; 2019; 14():1839-1854. PubMed ID: 31692478 [TBL] [Abstract][Full Text] [Related]
28. [Current position of new fixed-dose combination of tiotropium and olodaterol - its role in the treatment of chronic obstructive pulmonary disease in the Czech Republic]. Koblížek V; Svoboda M Vnitr Lek; 2016; 62(12):1011-1020. PubMed ID: 28139131 [TBL] [Abstract][Full Text] [Related]
29. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological treatment of stable COPD: need for a simplified approach. Hillas G; Papaporfyriou A; Dimakou K; Papaioannou AI Postgrad Med; 2020 Mar; 132(2):126-131. PubMed ID: 31852408 [TBL] [Abstract][Full Text] [Related]
31. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862 [TBL] [Abstract][Full Text] [Related]